Target intelligence / Profile preview

Transient outward potassium channel (Ito)

Target
Ito
Molecular classification
Ion channel, Voltage-gated potassium channel
01

Overview

The transient outward potassium channel is a voltage-gated ion channel primarily responsible for the rapid, early repolarization phase (Phase 1) of the cardiac action potential (StatPearls, PMID: 30725637). It is composed of alpha subunits, most notably Kv4.3 (encoded by KCND3) and Kv4.2 (encoded by KCND2), which often associate with regulatory beta-subunits like KChIP2 to modulate channel kinetics (UniProt, P51777). In the heart, these channels help determine the characteristic notch of the action potential and influence the plateau phase, which is critical for proper excitation-contraction coupling (PubMed, PMID: 15618538). Dysregulation or genetic mutations in these channels are strongly linked to cardiac arrhythmias, including Brugada syndrome, atrial fibrillation, and heart failure-related electrical remodeling (PubMed, PMID: 21135220). Pharmacological modulation of the transient outward current (Ito) is a strategy in antiarrhythmic therapy, with drugs like vernakalant targeting these channels to terminate atrial arrhythmias (PubMed, PMID: 18413443). However, because these channels are also expressed in the central nervous system where they regulate neuronal firing patterns, therapeutic targeting requires careful consideration of potential neurological side effects (PubMed, PMID: 11518771).

Other names
Ito channelVoltage-gated potassium channel subfamily D member 3KCND3Kv4.3Voltage-gated potassium channel subfamily D member 2KCND2Kv4.2A-type potassium channel
02

Mechanism of action

Inhibition of the transient outward potassium current (Ito) to prolong the early phase of cardiac repolarization and modulate action potential duration.

03

Biological functions

Cardiac repolarizationAction potential shapingNeuronal excitability regulationPhase 1 repolarizationFrequency-dependent regulation of firing
04

Disease associations

Atrial fibrillationBrugada syndromeHeart failureVentricular tachycardiaEarly repolarization syndromeEpilepsy
05

Safety considerations

Risk of pro-arrhythmiaPotential for neurological side effects due to CNS expressionAlteration of cardiac conduction velocityQT interval prolongation
06

Interacting drugs

Flecainide

6 more in the full profile.

07

Biomarkers

ECG J-point elevationST-segment morphologyKCND3 genetic variantsAction potential duration (APD) prolongation

Beyond the preview

Go deeper on Transient outward potassium channel (Ito).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient outward potassium channel (Ito).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call